Paper
8 January 2024 The PD-1 and PD-L1 checkpoint and the application of their inhibitors
Hanqiu Li
Author Affiliations +
Proceedings Volume 12924, Third International Conference on Biological Engineering and Medical Science (ICBioMed2023); 129242K (2024) https://doi.org/10.1117/12.3012850
Event: 3rd International Conference on Biological Engineering and Medical Science (ICBioMed2023), 2023, ONLINE, United Kingdom
Abstract
Immunotherapy has become a research hotspot in the field of tumor therapy due to its significant therapeutic effects. Since the discovery of PD-1/PD-L1, this pair of immune cell receptors and ligands has rapidly become an important area of research in tumor immunity and even immunology in general. Targeted drugs against PD-1/PD-L1 have also become an essential part of immunotherapy and provided new life opportunities for countless cancer patients. This article will review the background and significance of the discovery of PD-1/PD-L1, and systematically introduce their applications and related inhibitor drugs. On the other hand, although PD-1 and PD-L1 discoveries have had a groundbreaking impact on immunology, there are still some shortcomings and uncharted territories for their related targeted drugs. This article will show some of the drawbacks of the functions of PD-1/PD-L1 inhibitor drugs and future views of PD-1/PD-L1 related immune suppression treatments, in order to further understand its mechanism and provide new ideas for clinical treatment of malignant tumors.
© (2024) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Hanqiu Li "The PD-1 and PD-L1 checkpoint and the application of their inhibitors", Proc. SPIE 12924, Third International Conference on Biological Engineering and Medical Science (ICBioMed2023), 129242K (8 January 2024); https://doi.org/10.1117/12.3012850
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Tumors

Cancer

Molecules

Chemotherapy

Melanoma

Oncology

Radiotherapy

RELATED CONTENT


Back to Top